City of Hope Oncologist Surveyed about the Impact of Social Media on Clinical Trial Participation
The ongoing patient recruitment challenge continues throughout the information age, where less than 5% of eligible adults participate in cancer clinical trials despite the fact that in case after case lives are being extended by clinical trials. Although the research...
Hebrew University’s Hadassah Medical Center Spin-off Developing Type 2 Diabetes Drug
Insulin resistance, the leading cause of Type 2 diabetes, is the target of a new drug under development in Israel. Developed at the Hebrew University-Hadassah Medical Center laboratory of professor Mordechai Chevion, the intellectual property was licensed to the...
How Clinical Trial Sponsors Manage their Critical Documentation: A Recent Acquisition
Phlexglobal, a UK-based outsourced clinical trial master file service provider and software developer, has acquired Cunesoft, a niche Munich-based regulatory data and document management upstart from its shareholders, including Bayern Kapital, High-Tech Gründerfonds,...
New Cannabis-based Experimental Drugs could go into Clinical Trials for Huntington’s Disease and MS
MMJ International Holdings (MMJ), an entrepreneurial cannabis-based research and development venture with operations in the United States and Jamaica recently shared government hearings and what the venture’s principals hope, is a movement to loosen up cannabis laws...
Kazan Federal University-Led Research Showcases Potential
Based on work on extracellular microvesicles, a research team led by Kazan Federal University in Russia has derived from human mesenchymal stem cells (MSCs), a potential new form of cell-free therapy. The scientific collaborative continues to probe the therapeutic...
Novartis’ LOU64 Shows Early Promise to Combat Sjögren’s Syndrome—All Eyes on the LOUiSSE Trial
An experimental drug known as LOU064, an inhibitor of the Burton Tyrosine Kinase (BTK) protein, according to Novartis-funded research, can reduce the activation of B-cells in both lab dishes and in animal models pointing to therapeutic potential to fight diseases such...
Early-Stage OT-82 Developed by Roswell Park Comprehensive Cancer Center & Shows Promise to Fight High-Risk Leukemia
OT-82, a preclinical stage drug candidate developed at Roswell Park Comprehensive Cancer Center (RPCCC) Buffalo, shows promise as a treatment to fight high-risk leukemia. Licensed for R&D and commercialization to OncoTartis, a biotech venture organized by RPCCC’s...
Endless Ethical Quandary Created by High Drug Prices
Novaris-$900,000
A Billionaire’s ‘Cancer Moonshot’ Comes Down to Earth: But Could it Ever Really Fly?
As it turns out, even a billionaire faces tough constraints in the real-world of cancer-focused drug development. A well-intentioned but hyperbolic “cancer moonshot” pursued big achievements but, in reality, has fallen well short of its targets declared by 2020....
Belarus’ N.N. Alexandrov National Centre Brings Phase II Immune-Oncology Clinical Trial Agent Called Elenagen
The N.N. Alexandrov National Centre beings Phase II case-control clinical trial of its immune-oncology agent called Elenagen. The Study Inoperable late-stage cancer patients with triple-negative breast cancer, ovarian cancer, stomach cancer or prostate cancer will be...
Flawed Chronic Fatigue Research Isn’t Being Retracted from One of The World’s Leading Medical Journals
While acknowledging that the BMJ (formerly the British Medical Journal), along with its sister publications, is an admirable medical journal, Tuller, senior fellow in public health and journalism at UC Berkeley’s Center for Global Public Health, part of the...
Regional Health Network Collaborative Expands into More Care, Pulmonary Clinical Trials
Major health systems have joined forces in a multi-therapeutic area focused collaborative, centering on the Allegheny Health Network (AHN), creating one of the largest coordinated women’s gynecologic and obstetrical health research programs in the United States. Along...
Siteman Cancer Center Brings Advanced Research as a Care Option to Illinois
Siteman Cancer Center has expanded to another facility in Shiloh, Illinois, offering this new geographic location access to advanced clinical research programs for state-of-the-art clinical research as a care option. Because Siteman is a National Cancer...
Clinical Research as a Care Option in Baltimore Offered by The Sandra & Malcolm Berman Cancer Institute at GBMC
The Sandra and Malcolm Berman Cancer Institute at GBMC, a multidisciplinary team, manages clinical trials in the effort to bring progressive clinical research as care options to cancer care. But many in the community don’t trust clinical research. Hence, there is a...
Memorial Sloan Kettering Cancer Center Discusses the Importance of Clinical Trials Nurses
Memorial Sloan Kettering Cancer Center (MSK) clinical trial nurses require a special combination of attributes as a group caring for patients enrolling in first-in-human clinical trials. After all, these are the studies where a new drug is being administered in people...
Florida Cancer Specialists & Research Institute New Advanced Cancer Center to Support Clinical Trials
Florida Cancer Specialists & Research Institute (FCS) announced a new $16 million state-of-the-art facility in Lakewood Ranch, Florida, to house an advanced cancer center. The 10,820 square-foot center will include 38 chemotherapy chairs, 10 examination rooms,...
China’s ‘Thousand Talents Program’ Pierces Moffitt Cancer Center & Director Must Pay with Job
Moffit Cancer Center CEO Dr. Alan List is purportedly leaving the institution due a violation of the cancer center’s rules for conflict of interest due to some sort of research work with China. Recently, local media 8 On Your Side reported that an internal...
University of Cincinnati Investigator Fails to Seek Timely Approval tied to Human-Studies
A University of Cincinnati (UC) principal investigator failed to properly seek approval tied to the rights and welfare of human research subjects, according to the results of a recent UC investigation. Susan Kotowski not only ultimately failed to adhere to informed...
Summary of U.S. Vs. Sami Anwar Court Documentation and Exhibits
Sami Anwar was arrested on November 8, 2018. Prior to that, on November 6, 2018, the Grand Jury returned a 47-count Indictment charging the Defendant with, inter alia, devising and perpetrating a fraudulent scheme and artifice, referred to in the Indictment as the...
